SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001206774-11-000317
Filing Date
2011-02-25
Accepted
2011-02-25 17:15:35
Documents
8
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT geron_10k.htm 10-K 1306046
2 EXCLUSIVE LICENSE AGREEMENT BETWEEN THE REGISTRANT AND ANGIOCHEM, INC., exhibit10-22.htm EX-10.22 405327
3 TRANSITION AND SEPARATION AGREEMENT BETWEEN THE REGISTRANT AND THOMAS B. OKARMA exhibit10-35.htm EX-10.35 68967
4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM exhibti23-1.htm EX-23.1 8508
5 CERTIFICATION OF INTERIM CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER exhibit31-1.htm EX-31.1 10052
6 CERTIFICATION OF INTERIM CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL exhibit32-1.htm EX-32.1 5818
7 geron_10k10x9x1.jpg GRAPHIC 12170
8 geron_10k5x1x1.jpg GRAPHIC 61164
  Complete submission text file 0001206774-11-000317.txt   1907740
Mailing Address 200 CONSTITUTION DRIVE MENLO PARK CA 94025
Business Address 230 CONSTITUTION DRIVE MENLO PARK CA 94025 6504737700
GERON CORP (Filer) CIK: 0000886744 (see all company filings)

IRS No.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-20859 | Film No.: 11642152
SIC: 2834 Pharmaceutical Preparations